Evidence map›Paper›PMID 38429627›Full record

ArticleInternational journal of cancer2024

DeepCG: A cell graph model for predicting prognosis in lung adenocarcinoma.

Baoyi Zhang, Chenyang Li, Jia Wu, Jianjun Zhang, Chao Cheng

Abstract read
In one paragraph

Article in International journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Baoyi ZhangDepartment of Chemical and Biomolecular Engineering, Rice University, Houston, Texas, USA.
Chenyang LiGenomic Medicine Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jia WuDepartment of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jianjun ZhangGenomic Medicine Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chao ChengDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-5002-3417

Funding

An innovative integrated computational framework using gene signatures for patient stratificationR01CA269764 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CHAO CHENG · 2023 to 2026
$1.8M
NCI NIH HHS 1R01CA269764-01A1NCI NIH HHS R01 CA269764
6 · The paper itself

Abstract

Lung cancer is the first leading cause of cancer-related death in the United States, with lung adenocarcinoma as the major subtype accounting for 40% of all cases. To improve patient survival, image-based prognostic models were developed due to the ready availability of pathological images at diagnosis. However, the application of these models is hampered by two main challenges: the lack of publicly available image datasets with high-quality survival information and the poor interpretability of conventional convolutional neural network models. Here, we integrated matched transcriptomic and H&E staining data from TCGA (The Cancer Genome Atlas) to develop an image-based prognostic model, termed Deep-learning based Cell Graph (DeepCG) model. Instead of survival data, we used a gene signature to predict patient prognostic risks, which was then used as labels for training DeepCG. Importantly, by employing graph structures to capture cell patterns, DeepCG can provide cell-level interpretation, which was more biologically relevant than previous region-level insights. We validated the prognostic values of DeepCG in independent datasets and demonstrated its ability to identify prognostically informative cells in images.

Indexed as

Adenocarcinoma of LungLung NeoplasmsGene Expression ProfilingHumansPrognosisProportional Hazards Modelsgraph neural networkH&Elung adenocarcinomaprognosis

Identifiers

PMID38429627
PMCPMC11015971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.